U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.…
U.S. Physical Therapy Presented at the 18th Annual Southwest IDEAS Conference
U.S. Physical Therapy (NYSE: USPH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 4,653 employees.
The shares were at 95.93 USD on 20 November 2026, up 38.9% over 52 weeks. Its 52-week range is 58.19 USD to 101.37 USD: the price is 5.4% below the high and 64.9% above the low.
Its market capitalisation is 1.43B USD. It pays a dividend yielding 1.95%, against a median of 0.76% among the dividend payers in that peer group.
U.S. Physical Therapy reports return on equity of 3.2%, an operating margin of 10.2% and revenue up 13.1% year over year.
Its debt exceeds its cash by 380.25M USD, a debt-to-equity ratio of 0.66. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 111.50 USD is 16.2% above the current price. The next earnings report is expected on 24 February 2027.